• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular Risk in Patients with Chronic Kidney Disease with Special Reference to Statin Therapy.

作者信息

Kawada Tomoyuki

机构信息

Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8602, Japan.

出版信息

High Blood Press Cardiovasc Prev. 2022 Nov;29(6):625-626. doi: 10.1007/s40292-022-00549-y. Epub 2022 Oct 29.

DOI:10.1007/s40292-022-00549-y
PMID:36308641
Abstract
摘要

相似文献

1
Cardiovascular Risk in Patients with Chronic Kidney Disease with Special Reference to Statin Therapy.慢性肾脏病患者的心血管风险，特别提及他汀类药物治疗
High Blood Press Cardiovasc Prev. 2022 Nov;29(6):625-626. doi: 10.1007/s40292-022-00549-y. Epub 2022 Oct 29.
2
[Chronic renal insufficiency and cardiovascular disease].[慢性肾功能不全与心血管疾病]
Ann Cardiol Angeiol (Paris). 2009 Feb;58(1):40-52. doi: 10.1016/j.ancard.2008.07.010. Epub 2008 Aug 19.
3
Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins.血脂异常、慢性肾脏病、动脉粥样硬化性心血管疾病与他汀类药物
Cardiovasc Drugs Ther. 2022 Jun;36(3):569-570. doi: 10.1007/s10557-021-07284-x. Epub 2021 Nov 12.
4
Cardiovascular Risk Stratification and Appropriate Use of Statins in Patients with Chronic Kidney Disease According to Different Strategies.根据不同策略对慢性肾脏病患者进行心血管风险分层及他汀类药物的合理使用
High Blood Press Cardiovasc Prev. 2022 Sep;29(5):435-443. doi: 10.1007/s40292-022-00531-8. Epub 2022 Jun 25.
5
Is lipid management effective for all stages of CKD?血脂管理对 CKD 的所有阶段都有效吗？
Blood Purif. 2013;35(1-3):26-30. doi: 10.1159/000345932. Epub 2013 Jan 22.
6
Statins in chronic kidney disease: cardiovascular risk and kidney function.他汀类药物在慢性肾脏病中的应用：心血管风险与肾功能。
Postgrad Med. 2014 Jan;126(1):29-36. doi: 10.3810/pgm.2014.01.2722.
7
Further perspectives on statin use in patients with chronic kidney disease.关于慢性肾病患者使用他汀类药物的进一步观点。
Basic Clin Pharmacol Toxicol. 2022 Nov;131(5):303-305. doi: 10.1111/bcpt.13785. Epub 2022 Sep 7.
8
Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.他汀类药物和依折麦布联合治疗慢性肾脏病患者的效果和安全性：系统评价和荟萃分析。
Clin Pharmacol Ther. 2020 Oct;108(4):833-843. doi: 10.1002/cpt.1859. Epub 2020 May 13.
9
Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.他汀类药物对轻中度慢性肾脏病患者心血管事件的影响：随机临床试验的系统评价和荟萃分析。
BMC Cardiovasc Disord. 2014 Feb 17;14:19. doi: 10.1186/1471-2261-14-19.
10
Inflammation contributes to cardiovascular risk in patients receiving statin therapy.炎症会增加接受他汀类药物治疗患者的心血管疾病风险。
Lancet. 2023 Apr 15;401(10384):1245-1247. doi: 10.1016/S0140-6736(23)00454-3. Epub 2023 Mar 6.

本文引用的文献

1
Cardiovascular Risk Stratification and Appropriate Use of Statins in Patients with Chronic Kidney Disease According to Different Strategies.根据不同策略对慢性肾脏病患者进行心血管风险分层及他汀类药物的合理使用
High Blood Press Cardiovasc Prev. 2022 Sep;29(5):435-443. doi: 10.1007/s40292-022-00531-8. Epub 2022 Jun 25.
2
Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis.他汀类药物对慢性肾脏病患者肾功能的疗效：系统评价和荟萃分析。
Ren Fail. 2021 Dec;43(1):718-728. doi: 10.1080/0886022X.2021.1915799.
3
Chronic kidney disease and statin eligibility.
慢性肾脏病与他汀类药物适应证。
J Clin Lipidol. 2021 Jan-Feb;15(1):173-180. doi: 10.1016/j.jacl.2020.10.004. Epub 2020 Oct 31.
4
Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations.慢性肾脏病中的调脂治疗：病理生理学和临床考虑。
Pharmacol Ther. 2020 Mar;207:107459. doi: 10.1016/j.pharmthera.2019.107459. Epub 2019 Dec 18.
5
Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.不同类型他汀类药物对肾功能下降和蛋白尿的影响：网络荟萃分析。
Sci Rep. 2019 Nov 12;9(1):16632. doi: 10.1038/s41598-019-53064-x.
6
Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.肥胖与他汀类药物治疗期间动脉粥样硬化的进展相关。
J Am Heart Assoc. 2016 Jul 13;5(7):e003621. doi: 10.1161/JAHA.116.003621.